Dermal Fibroblasts-derived Exosomes Alleviated Bronchopulmonary Dysplasia in Neonatal Rats Partially by Regulating...

Area of Science:

• Neonatal Medicine
• Pulmonology
• Cell Biology
• Regenerative Medicine

Background:

• Bronchopulmonary dysplasia (BPD) is a chronic lung disease in preterm infants, marked by impaired lung development and inflammation.
• Dermal fibroblast-derived exosomes (DF-Exos) are known to reduce inflammation and aid tissue repair, but their effect on lung injury is unexplored.

Purpose of the Study:

• To investigate the therapeutic potential of DF-Exos in a hyperoxia-induced BPD rat model.
• To explore the relationship between DF-Exos treatment and autophagy in the context of BPD.

Main Methods:

• DF-Exos were isolated via ultracentrifugation.
• A BPD model was established in neonatal rats using 7 days of hyperoxia (90% O₂).
• Lung morphology, vascularization, inflammatory markers (IL-1β, IL-6, TNF-α, IL-10), and autophagy proteins (Beclin1, LC3B, p62) were analyzed.

Main Results:

• Hyperoxia induced alveolar simplification, reduced vascular density, and increased pro-inflammatory cytokines.
• DF-Exos treatment improved alveolar structure, increased microvascular density, and reduced inflammation.
• DF-Exos administration enhanced autophagy markers (increased Beclin1 and LC3B conversion, decreased p62).

Conclusions:

• DF-Exos partially ameliorated lung injury in the BPD model, promoting alveolar and vascular repair.
• The therapeutic effects of DF-Exos are linked to the enhancement of autophagic activity.
• Further research is needed to clarify mechanisms and determine optimal therapeutic doses, considering potential transient injury.